Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?
Does targeting of S1P receptors reduce microglial activation in multiple sclerosis?
What it found
No result found
We found no results in the registry or in papers.
What was tested
Treatment tested
- beetainterferoni -1a
- Fingolimod
- Natalizumab
Integrin alpha-4/beta-1 inhibitor|Integrin alpha-4/beta-7 inhibitor
What it measured
Other measures (1)
To evaluate the treatment effect of standard therapies using MRI parameters
MRI lesions
About this trial
In the sponsor's words
To evaluate weather the present multiple sclerosis therapies have an effect on microglial activation
Loading reviews and guidelines…
Related trials
- Risk of Progressive Multifocal Leukoencephalopathy Among …
Recruiting
Still running
- TDM-MS
Phase 4 · Status unknown
No result found
- SEP-1
Recruiting
Still running
- TERIFIN
Phase 4 · Completed
No result found
- Natalizumab and Chronic Inflammation
Phase 4 · Stopped early
Stopped early
- Observational Study of the Effect of Ozanimod on Fatigue …
Stopped early
Stopped early
History
Started
Nov 2013
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error